These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39334478)
1. Baseline evaluation of the World Health Organization (WHO) infection prevention and control (IPC) core components in Pacific Island Countries and Territories (PICTs). Leong M; Picton R; Wratten M; Mahe A; Zimmerman PA Antimicrob Resist Infect Control; 2024 Sep; 13(1):108. PubMed ID: 39334478 [TBL] [Abstract][Full Text] [Related]
2. Implementation of the infection prevention and control core components at the national level: a global situational analysis. Tartari E; Tomczyk S; Pires D; Zayed B; Coutinho Rehse AP; Kariyo P; Stempliuk V; Zingg W; Pittet D; Allegranzi B J Hosp Infect; 2021 Feb; 108():94-103. PubMed ID: 33271215 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)-based survey. Azak E; Sertcelik A; Ersoz G; Celebi G; Eser F; Batirel A; Cag Y; Ture Z; Ozturk Engin D; Yetkin MA; Kaygusuz S; Candevir A; Tartari E; Rello J; Alp E; Antimicrob Resist Infect Control; 2023 Feb; 12(1):11. PubMed ID: 36782267 [TBL] [Abstract][Full Text] [Related]
4. The first WHO global survey on infection prevention and control in health-care facilities. Tomczyk S; Twyman A; de Kraker MEA; Coutinho Rehse AP; Tartari E; Toledo JP; Cassini A; Pittet D; Allegranzi B Lancet Infect Dis; 2022 Jun; 22(6):845-856. PubMed ID: 35202599 [TBL] [Abstract][Full Text] [Related]
5. Core components of infection prevention and control programs at the facility level in Georgia: key challenges and opportunities. Deryabina A; Lyman M; Yee D; Gelieshvilli M; Sanodze L; Madzgarashvili L; Weiss J; Kilpatrick C; Rabkin M; Skaggs B; Kolwaite A Antimicrob Resist Infect Control; 2021 Feb; 10(1):39. PubMed ID: 33627194 [TBL] [Abstract][Full Text] [Related]
6. Evaluating infection prevention and control programs in Austrian acute care hospitals using the WHO Infection Prevention and Control Assessment Framework. Aghdassi SJS; Grisold A; Wechsler-Fördös A; Hansen S; Bischoff P; Behnke M; Gastmeier P Antimicrob Resist Infect Control; 2020 Jun; 9(1):92. PubMed ID: 32571434 [TBL] [Abstract][Full Text] [Related]
7. Infection prevention and control in Indonesian hospitals: identification of strengths, gaps, and challenges. Supriadi IR; Haanappel CP; Saptawati L; Widodo NH; Sitohang G; Usman Y; Anom IB; Saraswati RD; Heger M; Doevendans PA; Satari HI; Voor In 't Holt AF; Severin JA Antimicrob Resist Infect Control; 2023 Feb; 12(1):6. PubMed ID: 36732802 [TBL] [Abstract][Full Text] [Related]
8. A national survey on the implementation of key infection prevention and control structures in German hospitals: results from 736 hospitals conducting the WHO Infection Prevention and Control Assessment Framework (IPCAF). Aghdassi SJS; Hansen S; Bischoff P; Behnke M; Gastmeier P Antimicrob Resist Infect Control; 2019; 8():73. PubMed ID: 31080588 [TBL] [Abstract][Full Text] [Related]
9. Infection prevention and control in tertiary care hospitals of Bangladesh: results from WHO infection prevention and control assessment framework (IPCAF). Harun MGD; Anwar MMU; Sumon SA; Hassan MZ; Haque T; Mah-E-Muneer S; Rahman A; Abdullah SAHM; Islam MS; Styczynski AR; Kaydos-Daniels SC Antimicrob Resist Infect Control; 2022 Oct; 11(1):125. PubMed ID: 36203207 [TBL] [Abstract][Full Text] [Related]
10. Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: a study protocol. Harun MGD; Anwar MMU; Sumon SA; Hassan MZ; Mohona TM; Rahman A; Abdullah SAHM; Islam MS; Kaydos-Daniels SC; Styczynski AR BMC Health Serv Res; 2022 Oct; 22(1):1239. PubMed ID: 36207710 [TBL] [Abstract][Full Text] [Related]
11. First nationwide survey of infection prevention and control among healthcare facilities in Japan: impact of the national regulatory system. Nomoto H; Saito H; Ishikane M; Gu Y; Ohmagari N; Pittet D; Kunishima H; Allegranzi B; Yoshida M Antimicrob Resist Infect Control; 2022 Nov; 11(1):135. PubMed ID: 36352429 [TBL] [Abstract][Full Text] [Related]
12. Evaluating national infection prevention and control minimum requirements: evidence from global cross-sectional surveys, 2017-22. Tartari E; Tomczyk S; Twyman A; Rehse APC; Gomaa M; Talaat M; Shah AS; Sobel H; Toledo JP; Allegranzi B Lancet Glob Health; 2024 Oct; 12(10):e1620-e1628. PubMed ID: 39304235 [TBL] [Abstract][Full Text] [Related]
13. Implementation of the WHO core components of an infection prevention and control programme in two sub-saharan African acute health-care facilities: a mixed methods study. Wood R; Tembele W; Hema A; Somé A; Kinganda-Lusamaki E; Basilubo C; Lumembe R; Alama N; Mbunsu G; Zongo A; Ahuka S; Muyembe JJ; Leendertz F; Eckmanns T; Schubert G; Kagoné T; Makiala S; Tomczyk S Antimicrob Resist Infect Control; 2024 Jan; 13(1):4. PubMed ID: 38221629 [TBL] [Abstract][Full Text] [Related]
14. Assessing infection prevention and control structures in German hospitals after the COVID-19 pandemic using the WHO infection prevention and control assessment framework (IPCAF): results from 660 hospitals and comparison with a pre-pandemic survey. Rüther FD; Gropmann A; Hansen S; Behnke M; Geffers C; Aghdassi SJS Antimicrob Resist Infect Control; 2024 Sep; 13(1):103. PubMed ID: 39272204 [TBL] [Abstract][Full Text] [Related]
15. The status of infection prevention and control structures in Eastern China based on the IPCAF tool of the World Health Organization. Ni K; Jin D; Wu Z; Sun L; Lu Q Antimicrob Resist Infect Control; 2022 Mar; 11(1):46. PubMed ID: 35264208 [TBL] [Abstract][Full Text] [Related]
16. Testing of the WHO Infection Prevention and Control Assessment Framework at acute healthcare facility level. Tomczyk S; Aghdassi S; Storr J; Hansen S; Stewardson AJ; Bischoff P; Gastmeier P; Allegranzi B J Hosp Infect; 2020 May; 105(1):83-90. PubMed ID: 31870887 [TBL] [Abstract][Full Text] [Related]
17. Self-reported survey on infection prevention and control structures in healthcare facilities part of a national level healthcare associated infection surveillance network in India, 2019. Katoch O; Katyal S; Srivastav S; Rodrigues C; Rupali P; Chakrabarti A; Ray P; Tak V; Biswal M; Nath R; Mukhopadhyay C; Bhattacharya S; Padmaja K; Deotale V; Venkatesh V; Wattal C; Ma T; Nag VL; Ray R; Behera B; Baveja S; Karuna T; Singh SK; Fomda B; Devi SK; Das P; Khandelwal N; Verma P; Gaind R; Bhattacharyya P; Kumar P; Srivastava A; Iravane J; Majumdar T; Sharma R; Sankara D; Kalwaje Eshwara V; Varma M; Nazir S; Tripathy S; Mishra S; Dey A; Thangavelu P; Kapoor L; Malhotra R; Walia K; Guleria R; Mathur P Am J Infect Control; 2022 Apr; 50(4):390-395. PubMed ID: 34600081 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance in the Pacific Island countries and territories. Loftus M; Stewardson A; Naidu R; Coghlan B; Jenney A; Kepas J; Lavu E; Munamua A; Peel T; Sahai V; Tekoaua R; Tudravu L; Zinihite J; Cheng A; Rafai E; Peleg A BMJ Glob Health; 2020 Apr; 5(4):. PubMed ID: 32349993 [TBL] [Abstract][Full Text] [Related]
19. Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3). Zingg W; Storr J; Park BJ; Jernigan JA; Harbarth S; Grayson ML; Tacconelli E; Allegranzi B; Cardo D; Pittet D; Antimicrob Resist Infect Control; 2019; 8():74. PubMed ID: 31168366 [TBL] [Abstract][Full Text] [Related]
20. A nationwide survey on the implementation of infection prevention and control components in 1442 hospitals in the Republic of Korea: comparison to the WHO Infection Prevention and Control Assessment Framework (IPCAF). Jeong Y; Joo H; Bahk H; Koo H; Lee H; Kim K Antimicrob Resist Infect Control; 2022 May; 11(1):71. PubMed ID: 35562838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]